Carlos Cruchaga, PhD, is a professor of psychiatry, genetics and neurology at the Washington University School of Medicine. His research focuses on using high-throughput approaches to understand the pathobiology of complex neurodegenerative disorders, such as Alzheimer’s disease (AD), and to identify new therapeutic targets. He is the current director of the Hope Center DNA and RNA Core and the Knight-ADRC Genetics Core, co-director of the Dominantly Inherited Alzheimer Network (DIAN) Genetics Core and scientific advisor for the McDonnell Genome Institute at Washington University. His lab generates large catalogs of data on gene sequences, genetic modifications, RNAs, proteins, metabolites and lipids from the brain, cerebrospinal fluid and plasma of large, well-characterized cohorts to enable identification of novel genes, variants and pathways associated with biomarkers and disease progression in AD and Parkinson’s disease. Dr. Cruchaga received a doctorate in biochemistry and molecular biology from the University of Navarra in Spain.